Quantcast

Empire State Today

Saturday, December 21, 2024

FDA conducted second highest number of inspections on Biologics companies in New York during September

Webp qdyp3hg0n6fiilgeuxkf5yj3s0lo

Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website

Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website

In September, three Biologics companies received three FDA inspections in New York, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in New York, equalling 18.8% of all inspections in September.

Of all the New York companies involved in Biologics, NYU Langone Hospitals received the most citations from the FDA in September.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in New York During September
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products11--
Compliance: Devices1----
Food Composition, Standards, Labeling and Econ--2--
Foodborne Biological Hazards74--
Human Cellular, Tissue, and Gene Therapies1----
Monitoring of Marketed Animal Drugs, Feed, and Devices1----
Postmarket Assurance: Devices1----

MORE NEWS